RapidAI Funding & Investors
San Mateo, CA
RapidAI empowers clinicians to make faster, more accurate diagnostic and treatment decisions for stroke and aneurysm patients. RapidAI's platform uses artificial intelligence to create advanced images from non-contrast CT, CT Angiography, CT perfusion, and MRI diffusion and perfusion scans. It was founded in 2011 and headquartered in Menlo Park, California.
rapidai.comTotal Amount Raised: $100,000,000
RapidAI Funding Rounds
Series C
$75,000,000
Series C Investors
Vista Equity PartnersSeries B
$25,000,000
Series B Investors
Lennertz & Co.
Funding info provided by Diffbot.